Alpha-GPC: Benefits, Dosage, and What the Research Actually Shows
By Peter Benson, Cognitive Enhancement Researcher · Updated October 2026 · Citations re-verified
Short answer: Alpha-GPC benefits are best supported in people with Alzheimer’s disease or mild cognitive impairment, and very little in healthy adults: one small single-dose trial in which one of three tests improved. Two large Korean studies disagree on whether it raises or lowers stroke risk. It is a reasonable occasional experiment, not a proven enhancer.
⚕️ Educational information, not medical advice — full disclaimer. This page contains one affiliate link, in the buying section.
Alpha-GPC is sold as one of the stronger choline supplements for memory and focus, and its reputation rests on real clinical trials. Those trials were run in people with Alzheimer’s disease and mild cognitive impairment. What alpha-GPC does for a healthy adult who wants to work better is a different question, and it has barely been studied.
This guide covers what the trials enrolled and measured, the doses they used, the conflicting evidence on stroke risk, and how to test alpha-GPC on yourself if you decide to. For the wider picture, see the Nootropics & Supplements guide. If this would be your first supplement, start with our beginners guide; alpha-GPC is not where I’d begin.
Alpha-GPC Dosage & Timing
Doses used in the trials. This is what was studied, not a prescription. Read the side effects and interactions section first, and speak with a doctor if you have cardiovascular risk factors.
| Dose in healthy adults | 315mg or 630mg, as a single dose, in the one acute cognitive trial. A two-week motivation study used 400mg a day. |
| Dose in clinical trials | 600mg a day in mild cognitive impairment and 1,200mg a day in Alzheimer’s disease. These are doses for impaired populations, not targets for healthy adults. |
| Form to check | Active alpha-GPC versus total powder. Many products use a 50% powder, so a “300mg” capsule may hold 150mg of active alpha-GPC. |
| Timing in trials | Testing took place 60 minutes after the dose in the acute trial. The motivation study gave it at bedtime. |
| Time to effect | Acute. The healthy-adult effect was measured an hour after a single dose. Nothing shows what daily use does in healthy people. |
| Upper limit | Total choline from food and supplements should stay under the adult upper limit of 3,500mg a day. |
Does alpha-GPC work? What the human trials show
Healthy adults
The best evidence is one trial. Twenty resistance-trained men took placebo, 315mg or 630mg in a randomised, double-blind crossover and were tested 60 minutes later. Stroop scores improved more than on placebo at both doses: by 13.0 points at 630mg and 10.8 at 315mg, against 5.2 on placebo. The Flanker and N-back tests showed no significant difference (Kerksick, 2024).
Three things limit that result. It was a single dose in 20 men, so it says nothing about women, older adults or daily use. Only one of three tests moved, and the author notes that a stricter correction for multiple comparisons might have changed the outcome. And the study was funded by an alpha-GPC supplier, with the author a paid scientific adviser to that company.
The same paper summarises an earlier study of 200mg and 400mg in 20 healthy men and women, which found no statistically significant cognitive changes. A separate two-week study gave 39 healthy volunteers 400mg at bedtime: self-rated motivation at night was significantly higher than on placebo, overall motivation showed only a tendency to rise, and anxiety was unchanged (Tamura et al., 2021). That study was single-blind and relied on self-report, which makes it the kind of result most open to expectation.
In practice: there is a hint of a same-day effect on one attention task, and no evidence about memory, about daily use, or about anyone other than young men.
Mild cognitive impairment
In 100 adults aged 55 to 85 with amnestic mild cognitive impairment, 600mg once a day for 12 weeks lowered the ADAS-cog score by 2.34 points, significantly more than placebo, with no serious adverse events (Jeon et al., 2024). The trial was supported by Suheung and used a branded capsule. It is a short trial in people with a diagnosis, so it does not show what alpha-GPC does for someone with normal memory.
Alzheimer’s disease
The trial behind most of alpha-GPC’s reputation is a multicentre, double-blind, placebo-controlled study in mild-to-moderate Alzheimer’s dementia at 400mg three times a day, which reported cognitive improvement over placebo with good tolerability (De Jesus Moreno Moreno, 2003). The Alzheimer’s Drug Discovery Foundation notes that participants were not taking current Alzheimer’s medicines, and that a later suggestion of benefit when alpha-GPC is added to those medicines has not been confirmed.
Alpha-GPC has also been compared directly with citicoline in three older dementia trials, covered in our citicoline vs alpha-GPC comparison. All three gave the compounds by injection.
Alpha-GPC benefits: the evidence by outcome
🟢 Stronger or replicated human evidence · 🟡 Limited, mixed or preliminary human evidence · 🔴 Not established
How alpha-GPC works
Choline is the raw material for acetylcholine, a neurotransmitter involved in memory and attention, and for phosphatidylcholine, a main component of cell membranes. Alpha-GPC is roughly 40% choline by weight, about twice the share in citicoline, and is described as a precursor that can raise acetylcholine in the brain. That is the proposed route for any cognitive effect.
More choline per capsule does not guarantee more benefit. The US Office of Dietary Supplements notes that a systematic review of 13 studies found choline supplements did not clearly improve cognition in healthy adults.
The claim that alpha-GPC is “more bioavailable” than citicoline also needs care. The study usually cited is Gatti and colleagues (1992), who gave 12 volunteers 1,000mg of each compound by intramuscular injection. Alpha-GPC raised plasma choline considerably more. An injection bypasses digestion and the liver, so this says little about a swallowed capsule, and no oral head-to-head has been done.
Alpha-GPC is also sold to athletes. The studies behind that are small: growth hormone rose an hour after 1,000mg in eight men and after 600mg in seven, and two short studies in young men reported gains in force production or jump power. They are worth knowing about and too small to build on.
Alpha-GPC and stroke risk: two studies, opposite answers
The safety question that matters most is stroke. A South Korean cohort study followed more than 12 million people aged 50 and over, with no prior stroke or Alzheimer’s disease, using national health insurance records from 2009 to 2018. The 108,877 who used alpha-GPC had a higher rate of stroke: an adjusted hazard ratio of 1.43 for any stroke, 1.34 for ischaemic stroke and 1.37 for haemorrhagic stroke, with risk rising as intake rose (Lee et al., 2021).
A later study from the same national database points the other way. Among 508,107 people newly diagnosed with mild cognitive impairment, the 77% who used alpha-GPC were less likely to progress to Alzheimer’s dementia (hazard ratio 0.90) or vascular dementia (0.83). Among those who did not progress, users also had fewer strokes: hazard ratios of 0.81 for ischaemic and 0.84 for haemorrhagic stroke (Kim et al., 2025). The authors note they had no cognitive test scores, did not analyse dose, and relied on diagnostic codes.
Both studies are observational, so neither can show that alpha-GPC caused the difference. Both identified users from national health insurance records, so these were people given alpha-GPC through the health system, and they may differ from non-users in ways that statistical adjustment does not capture. The two studies also looked at different groups: the general population over 50 in one, people already diagnosed with mild cognitive impairment in the other. The fair reading is that the stroke question is open, not that alpha-GPC is proven harmful or proven protective.
One mechanism has been proposed for harm. The US Office of Dietary Supplements explains that gut bacteria convert some choline to trimethylamine, which the liver turns into trimethylamine-N-oxide (TMAO), “a substance that has been linked to a higher risk of cardiovascular disease.” Alpha-GPC is a concentrated choline source. Whether that matters at supplement doses is not known.
My own position: the benefit in healthy adults is small and uncertain, so it takes little risk to outweigh it. If you are over 50, or have high blood pressure, raised cholesterol or a family history of stroke or heart disease, talk to a doctor before taking alpha-GPC, or leave it alone. Our nootropic safety guide explains this way of weighing a small upside against an unquantified downside.
Alpha-GPC vs citicoline
Citicoline is the usual alternative. It carries about half as much choline per milligram and also supplies cytidine. Its healthy-adult evidence is a 12-week memory trial in 100 older adults and a 28-day attention trial in 60 women, both with maker involvement, and the European Food Safety Authority judged the memory evidence insufficient in 2024. No large study has examined citicoline and stroke risk in either direction. Neither compound has been shown to beat the other by mouth. The full breakdown is in our citicoline vs alpha-GPC comparison.
🧮 Worked example — reading an alpha-GPC label correctly
Say you want to match the 315mg used in the healthy-adult trial, and you are comparing two products.
Product A: “Alpha-GPC 300mg (50%)”. The 50% means each capsule is half active: 300mg of powder × 0.5 = 150mg active. Two capsules give 300mg, close to the trial dose.
Product B: “Alpha-GPC 300mg (99%)”. Here 300mg of powder is about 297mg active, so one capsule is close to the trial dose.
Product C: “Alpha-GPC 150mg” with no percentage. You can’t tell whether that is active compound or powder. Check the supplement facts panel or the certificate of analysis, or ask the seller, before you count capsules.
The trap is only in misreading the label. Someone taking one capsule of Product A believes they are at 300mg, is actually at 150mg, and may wrongly conclude that alpha-GPC does nothing. If you get no effect at the trial dose, the answer is to stop, not to keep raising it.
The NeuroEdge Formula Alpha-GPC Self-Testing Framework
How to find out whether alpha-GPC does anything for you. It lists what the trials used; it is not a prescription.
One compound at a time
Test alpha-GPC on its own. Don’t start it alongside Bacopa, citicoline or anything else new, or you won’t know what caused any change.
Match the trial
The healthy-adult trial used a single 315mg or 630mg dose, tested an hour later. Start at the lower one, and confirm the active figure on your label.
Measure on and off days
The effect is same-day, so compare several on days and off days over a couple of weeks, using a short timed attention task. Expect a small effect at most; it may take many sessions to tell from normal variation.
When to stop
If your scores stay inside your normal range, conclude it does nothing detectable for you. Occasional use on demanding days keeps total choline exposure low.
For how to set a baseline and read your own results, see our self-testing method.
Peter’s Testing Notes
A personal impression, not tracked data
On its own. I took 300mg of a Nootropics Depot alpha-GPC in the morning, sometimes again around 2pm on heavy days, four or five times a week for about three months. The first hour of deep work felt cleaner. My caffeine intake also varied over that time, so I can’t credit alpha-GPC fully.
Side effects. Occasional mild headaches after three or four days in a row, which faded after 48 hours off. Once, I doubled up on choline by taking alpha-GPC with citicoline and got a tension headache behind the eyes within hours. When I tried taking alpha-GPC at night alongside magnesium, I took longer to fall asleep, so I moved it to mornings only.
In a stack. Later I took it with Bacopa for about four months and noticed cleaner recall around week eight. I never ran the two separately for the same length of time, so I can’t say what alpha-GPC added. That combination has not been tested in a trial; see the nootropic stacking guide.
None of this was blinded or measured. An earlier version of this page described tracked cognitive-test scores; that was not accurate and has been removed.
Choosing an alpha-GPC supplement
Alpha-GPC absorbs moisture readily, which is why many products use a 50% powder that is easier to keep stable in a capsule. That is fine at a matched active dose. What matters is that the label tells you how much active alpha-GPC you are getting, and that the product comes with third-party testing.
Nootropics Depot Alpha GPC — standalone alpha-GPC
Third-party lab tested, with certificates of analysis published by lot. Their capsules list 150mg of alpha-GPC each. A standalone product lets you test alpha-GPC on its own.
This is an affiliate link. If you buy through it, NeuroEdge Formula may earn a commission at no extra cost to you. My conclusion above is that many readers do not need alpha-GPC.
Who alpha-GPC suits, and who should skip it
Illustrative examples, not real individuals or testimonials. These composite situations show how the reasoning above applies. They describe no real people and no outcomes. Individual responses vary.
The occasional user
Someone under 50 with no cardiovascular risk factors who wants to try it before a few demanding days a month. This is the closest match to the one healthy-adult trial, and occasional use keeps choline exposure low. The realistic expectation is a small effect or none.
The daily-stack builder
Someone planning to take it every morning indefinitely. No trial has tested daily use in healthy adults, so this goes beyond the evidence. Testing it on and off first is the cheaper way to find out whether it earns a place.
The over-50 with a family history
Here the stroke question moves from footnote to deciding factor. The two cohort studies disagree, and that uncertainty is itself the reason to speak to a doctor first, or to skip a supplement whose benefit in healthy people is unproven.
The athlete
Pre-training use rests on small, short studies of growth hormone and power. Any perceived benefit could be the compound, the training or expectation, and personal impression cannot separate them.
Alpha-GPC Side Effects & Interactions
Stroke and cardiovascular risk. One large observational study linked alpha-GPC to higher stroke risk in people aged 50 and over; another found lower risk in users with mild cognitive impairment. The question is unresolved. If you are over 50, or have high blood pressure, raised cholesterol or a family history of stroke or heart disease, discuss it with your doctor first.
Side effects. Few studies have reported on them. Those documented are mostly mild: constipation, nervousness, heartburn, headache, insomnia, dizziness, rash and confusion. The 12-week trial in mild cognitive impairment reported no serious adverse events.
Medicines. The one reported drug interaction is with scopolamine, an anticholinergic used for motion sickness. Because alpha-GPC acts on the same system, tell your prescriber if you take any anticholinergic medicine or a cholinesterase inhibitor such as donepezil.
Total choline. Very high choline intakes are associated with a fishy body odour, vomiting, sweating, low blood pressure and liver toxicity. Keep choline from all sources under the adult upper limit of 3,500mg a day.
Pregnancy and breastfeeding. Alpha-GPC supplements have not been studied in pregnancy or breastfeeding. Avoid them unless a doctor advises otherwise.
This is not a complete list. Sources: the Alzheimer’s Drug Discovery Foundation and the NIH Office of Dietary Supplements.
Key takeaways
| → | The clinical evidence is in impaired populations: Alzheimer’s disease at 1,200mg a day and mild cognitive impairment at 600mg a day. |
| → | Healthy-adult evidence is one small trial: 20 men, a single dose, one of three tests improved, sponsor-funded. |
| → | “More bioavailable than citicoline” is not established. The study usually cited used injections. |
| → | The stroke question is open. Two large Korean studies point in opposite directions, and both are observational. |
| → | Check the label. With 50% products, the figure may be total powder, not active alpha-GPC. |
| → | If you try it, test it alone on and off over a couple of weeks, and stop if you can’t detect an effect. |
Frequently asked questions
What is alpha-GPC used for?
As a supplement, it is sold for memory, focus and pre-workout use. In research it has been studied mainly in Alzheimer’s disease and mild cognitive impairment, where trials at 600mg to 1,200mg a day reported cognitive improvement. Evidence in healthy adults is limited to one small single-dose trial and a two-week motivation study.
How long does alpha-GPC take to work?
In the one healthy-adult trial, testing took place 60 minutes after a single dose, so any effect is same-day. The clinical trials in people with impairment measured outcomes after 12 weeks and longer. Nothing shows a build-up effect in healthy people.
Should I take alpha-GPC every day?
No trial has tested daily use in healthy adults, so there is no evidence either way. Because the measured effect was acute, using it only on demanding days fits the evidence better and keeps your total choline intake lower. Nothing in the trials suggests a need to cycle it.
Can I take alpha-GPC with caffeine?
The trials covered here tested alpha-GPC on its own, so there is no trial evidence on the combination. If you want to know what alpha-GPC does for you, keep your caffeine intake the same on test days and off days.
Is alpha-GPC the same as choline?
It is one source of choline. Alpha-GPC is about 40% choline by weight. The adequate intake of choline is 550mg a day for adult men and 425mg for adult women from all sources, and eggs, meat, fish and dairy supply it. Most people eating a varied diet do not need a supplement to reach that figure.
Get “7 Days to a Sharper Brain” — Free
Peter Benson’s evidence-first starting framework
The habits with the strongest evidence first — sleep, movement, stress and learning — then how to add a single supplement and test whether it actually works for you.
No spam. Unsubscribe anytime.
⚕️ Educational Information, Not Medical Advice
This article is educational and is not medical advice. I’m a cognitive enhancement researcher, not a medical doctor. Alpha-GPC acts on cholinergic neurotransmission and may interact with anticholinergic medicines. Observational studies disagree on whether it raises or lowers stroke risk. Consult a qualified healthcare provider before use, particularly if you take medication, have cardiovascular risk factors, are pregnant or breastfeeding, or have a neurological condition.
Scientific references
1. Kerksick, C. M. (2024). Acute alpha-glycerylphosphorylcholine supplementation enhances cognitive performance in healthy men. Nutrients, 16(23), 4240. Link (Funded by NNB Nutrition; the author is a paid adviser to the sponsor.)
2. Tamura, Y., Takata, K., Matsubara, K., & Kataoka, Y. (2021). Alpha-glycerylphosphorylcholine increases motivation in healthy volunteers: a single-blind, randomized, placebo-controlled human study. Nutrients, 13(6), 2091. Link
3. Jeon, et al. (2024). Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial. BMC Geriatrics. DOI: 10.1186/s12877-024-05366-7
4. De Jesus Moreno Moreno, M. (2003). Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics, 25(1), 178–193. PMID: 12637119
5. Lee, G., et al. (2021). Association of L-α glycerylphosphorylcholine with subsequent stroke risk after 10 years. JAMA Network Open. Link
6. Kim, H.-K., Park, S., Kim, S.-W., et al. (2025). Association between L-α glycerylphosphorylcholine use and delayed dementia conversion: a nationwide longitudinal study in South Korea. The Journal of Prevention of Alzheimer’s Disease. Link
7. Sagaro, G. G., & Amenta, F. (2025). Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis. Frontiers in Neurology, 16, 1649661. DOI: 10.3389/fneur.2025.1649661
8. Gatti, G., Barzaghi, N., Acuto, G., Abbiati, G., Fossati, T., & Perucca, E. (1992). A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 30(9), 331–335. PMID: 1428296
9. National Institutes of Health, Office of Dietary Supplements. Choline: Fact Sheet for Health Professionals. Updated June 2022. ods.od.nih.gov
10. Alzheimer’s Drug Discovery Foundation. Cognitive Vitality: Alpha-GPC (choline alfoscerate). Updated March 2020. ADDF
Cognitive Enhancement Researcher | 18+ Years Independent Research
Peter is not a clinician; this guide is educational, not medical advice. It was updated in October 2026 to add newer trials, both Korean cohort studies on stroke risk, and his own impression-only notes. Read about how NeuroEdge Formula evaluates research.
Last reviewed: October 2026







